Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA.

Congenital factor XIII (FXIII) deficiency is potentially a severe bleeding disorder, but in some cases, the symptoms may be fairly mild. In this study, we have characterized the molecular mechanism of a mild phenotype of FXIII A-subunit deficiency in a Finnish family with two affected sisters, one of whom has even had two successful pregnancies without regular substitution therapy. In the screening tests for FXIII deficiency, no A-subunit could be detected, but by using more sensitive assays, a minute amount of functional A-subunit was seen. 3H-putrescine incorporation assay showed distinct FXIII activity at the level of 0.35% of controls, and also the fibrin cross-linking pattern in the patients clotted plasma showed partial gamma-gamma dimerization. In Western blot analysis, a faint band of full-length FXIII A-subunit was detected in the patients' platelets. The patients have previously been identified as heterozygotes for the Arg661 --> Stop mutation. Here we report a T --> C transition at position +6 of intron C in their other allele. The transition affected splicing of FXIII mRNA resulting in low steady state levels of several variant mRNA transcripts. One transcript contained sequences of intron C, whereas two transcripts resulted from skipping of one or two exons. Additionally, correctly spliced mRNA lacking the Arg661 --> Stop mutation of the maternal allele could be detected. These results demonstrate that a mutation in splice donor site of intron C can result in several variant mRNA transcripts and even permit partial correct splicing of FXIII mRNA. Further, even the minute amount of correctly processed mRNA is sufficient for producing protein capable of gamma-gamma dimerization of fibrin. This is a rare example of an inherited functional human disorder in which a mutation affecting splicing still permits some correct splicing to occur and this has a beneficial effect to the phenotype of the patients.

[1]  P. Board,et al.  New Mutations Causing the Premature Termination of Translation in the A Subunit Gene of Coagulation Factor XIII , 1996, Thrombosis and Haemostasis.

[2]  R. Ádány,et al.  Three Different Cell Types Can Synthesize Factor XIII Subunit A in the Human Liver , 1996, Thrombosis and Haemostasis.

[3]  A. Tosetto,et al.  Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain. , 1996, Blood.

[4]  嘉村 巧.  Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5' end of exon III , 1996 .

[5]  L. Peltonen,et al.  Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit. , 1996, Blood.

[6]  W. Miller,et al.  T-->A transversion 11 bp from a splice acceptor site in the human gene for steroidogenic acute regulatory protein causes congenital lipoid adrenal hyperplasia. , 1995, Human molecular genetics.

[7]  A. Stewart,et al.  Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function , 1995, British journal of haematology.

[8]  V. Yee,et al.  Factor XIIIA calgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit , 1995, British journal of haematology.

[9]  P. Vreken,et al.  A Point Mutation in an Invariant Splice Acceptor Site Results in a Decreased mRNA Level in a Patient with Severe Coagulation Factor XIII Subunit A Deficiency , 1995, Thrombosis and Haemostasis.

[10]  S. Antonarakis.  Molecular Genetics of Coagulation Factor VIII Gene and Hemophilia A , 1995, Thrombosis and Haemostasis.

[11]  D. Goldstein,et al.  Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus , 1994, Nature Genetics.

[12]  L. Pedersen,et al.  Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Peltonen,et al.  Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. , 1994, Blood.

[14]  D. Umetsu,et al.  Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency. , 1994, American journal of human genetics.

[15]  M. Paulsson,et al.  Transglutaminases: Protein Cross-Linking Enzymes in Tissues and Body Fluids , 1994, Thrombosis and Haemostasis.

[16]  M. Losowsky,et al.  Factor XIII: inherited and acquired deficiency. , 1993, Blood reviews.

[17]  D. Bowen,et al.  Factor XIII ABristol 1: detection of a nonsense mutation (Arg171→+stop codon) in factor XIII A subunit deficiency , 1993, British journal of haematology.

[18]  A. Ichinose,et al.  Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII. , 1993, Blood.

[19]  Z. Boda,et al.  Platelet Factor XIII Becomes Active without the Release of Activation Peptide during Platelet Activation , 1993, Thrombosis and Haemostasis.

[20]  P. Board,et al.  Identification of a point mutation in factor XIII A subunit deficiency. , 1992, Blood.

[21]  T. Kamura,et al.  Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5' end of exon III. , 1992, The Journal of clinical investigation.

[22]  S. N. Murthy,et al.  Intramolecular crosslinking of monomeric fibrinogen by tissue transglutaminase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K Kontula,et al.  A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. , 1990, Genomics.

[24]  S. N. Murthy,et al.  Cross-linked A alpha.gamma chain hybrids serve as unique markers for fibrinogen polymerized by tissue transglutaminase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Okafuji,et al.  A familial factor XIII subunit B deficiency , 1990, British journal of haematology.

[26]  A. Syvänen,et al.  Direct sequencing of affinity‐captured amplified human DNA application to the detection of apolipoprotein E polymorphism , 1989, FEBS letters.

[27]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Y. Ohshima,et al.  Signals for the selection of a splice site in pre-mRNA. Computer analysis of splice junction sequences and like sequences. , 1987, Journal of molecular biology.

[29]  P. Henriksson,et al.  Identification of intracellular factor XIII in human monocytes and macrophages. , 1985, The Journal of clinical investigation.

[30]  R. Ádány,et al.  Factor XIII of blood coagulation in human monocytes. , 1985, Thrombosis research.

[31]  Tom Maniatis,et al.  Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes , 1983, Nature.

[32]  L. Lorand,et al.  A filter paper assay for transamidating enzymes using radioactive amine substrates. , 1972, Analytical biochemistry.

[33]  S. Pizzo,et al.  The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. , 1971, The Journal of clinical investigation.

[34]  J. Mcdonagh,et al.  Factor XIII in human plasma and platelets. , 1969, The Journal of clinical investigation.